| URL | https://richmond.com/business/pharmaceutical-ingre |
| Source | Richmond Times-Dispatch |
| Date Published | 05/04/2021 |
| Author Name | John Reid Blackwell |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | AMPAC Fine Chemicals |
| Parent company | SK pharmteco |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 156 |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2023 |
| Capital investment ($): | 25 |
| City reshored to: | Petersburg |
| State(s) reshored to: | VA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | active pharmaceutical ingredients |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Government Incentives, Infrastructure, Lead time/Time to market, Proximity to customers/market, Skilled workforce availability/training, Under-utilized capacity, Other, import replacement |